Cargando…
De Novo KRAS G12C–Mutant SCLC: A Case Report
The application of KRAS G12C inhibitors in the setting of NSCLC represents a major milestone for a previously “undruggable” target. Here, we present the second reported case of de novo KRAS G12C–mutant primary SCLC. Would our patient benefit from a KRAS G12C inhibitor?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010630/ https://www.ncbi.nlm.nih.gov/pubmed/35434667 http://dx.doi.org/10.1016/j.jtocrr.2022.100306 |
_version_ | 1784687521222885376 |
---|---|
author | Balbach, Meridith L. Eisenberg, Rosana Iams, Wade T. |
author_facet | Balbach, Meridith L. Eisenberg, Rosana Iams, Wade T. |
author_sort | Balbach, Meridith L. |
collection | PubMed |
description | The application of KRAS G12C inhibitors in the setting of NSCLC represents a major milestone for a previously “undruggable” target. Here, we present the second reported case of de novo KRAS G12C–mutant primary SCLC. Would our patient benefit from a KRAS G12C inhibitor? |
format | Online Article Text |
id | pubmed-9010630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90106302022-04-16 De Novo KRAS G12C–Mutant SCLC: A Case Report Balbach, Meridith L. Eisenberg, Rosana Iams, Wade T. JTO Clin Res Rep Case Report The application of KRAS G12C inhibitors in the setting of NSCLC represents a major milestone for a previously “undruggable” target. Here, we present the second reported case of de novo KRAS G12C–mutant primary SCLC. Would our patient benefit from a KRAS G12C inhibitor? Elsevier 2022-03-19 /pmc/articles/PMC9010630/ /pubmed/35434667 http://dx.doi.org/10.1016/j.jtocrr.2022.100306 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Balbach, Meridith L. Eisenberg, Rosana Iams, Wade T. De Novo KRAS G12C–Mutant SCLC: A Case Report |
title | De Novo KRAS G12C–Mutant SCLC: A Case Report |
title_full | De Novo KRAS G12C–Mutant SCLC: A Case Report |
title_fullStr | De Novo KRAS G12C–Mutant SCLC: A Case Report |
title_full_unstemmed | De Novo KRAS G12C–Mutant SCLC: A Case Report |
title_short | De Novo KRAS G12C–Mutant SCLC: A Case Report |
title_sort | de novo kras g12c–mutant sclc: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010630/ https://www.ncbi.nlm.nih.gov/pubmed/35434667 http://dx.doi.org/10.1016/j.jtocrr.2022.100306 |
work_keys_str_mv | AT balbachmeridithl denovokrasg12cmutantsclcacasereport AT eisenbergrosana denovokrasg12cmutantsclcacasereport AT iamswadet denovokrasg12cmutantsclcacasereport |